ExodusPoint Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,634,838
| Closed | -$4.58M | – | 1345 |
|
|
2024
Q3 | $4.58M | Buy |
1,634,838
+1,343,724
| +462% | +$3.76M | 0.03% | 416 |
|
|
2024
Q2 | $678K | Buy |
291,114
+128,091
| +79% | +$298K | ﹤0.01% | 1012 |
|
|
2024
Q1 | $729K | Sell |
163,023
-299,804
| -65% | -$1.34M | 0.01% | 930 |
|
|
2023
Q4 | $1.49M | Buy |
462,827
+352,837
| +321% | +$1.13M | 0.01% | 620 |
|
|
2023
Q3 | $349K | Sell |
109,990
-317,762
| -74% | -$1.01M | ﹤0.01% | 1325 |
|
|
2023
Q2 | $2.13M | Sell |
427,752
-247,527
| -37% | -$1.23M | 0.02% | 703 |
|
|
2023
Q1 | $3.34M | Sell |
675,279
-483,422
| -42% | -$2.39M | 0.03% | 585 |
|
|
2022
Q4 | $7.29M | Buy |
1,158,701
+935,460
| +419% | +$5.88M | 0.11% | 240 |
|
|
2022
Q3 | $2.41M | Buy |
223,241
+192,738
| +632% | +$2.08M | 0.03% | 678 |
|
|
2022
Q2 | $348K | Sell |
30,503
-18,857
| -38% | -$215K | ﹤0.01% | 1431 |
|
|
2022
Q1 | $450K | Sell |
49,360
-84,940
| -63% | -$774K | 0.01% | 1534 |
|
|
2021
Q4 | $2M | Buy |
+134,300
| New | +$2M | 0.02% | 725 |
|
|
2021
Q3 | – | Sell |
-12,475
| Closed | -$325K | – | 2006 |
|
|
2021
Q2 | $325K | Buy |
12,475
+1,941
| +18% | +$50.6K | ﹤0.01% | 1615 |
|
|
2021
Q1 | $372K | Buy |
+10,534
| New | +$372K | 0.01% | 1490 |
|